American Journal of Respiratory and Critical Care Medicine Vol 165. pp. 1557-1565, (2002)
© 2002 American Thoracic Society
Pulmonary Interstitial Glycogenosis
A New Variant of Neonatal Interstitial Lung Disease
Anne-Marie Canakis,
Ernest Cutz,
David Manson and
Hugh O'Brodovich
Division of Respiratory Medicine, Departments of Paediatrics and Physiology, Division of Pathology, Departments of Paediatric Laboratory Medicine and Diagnostic Imaging of the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Correspondence and requests for reprints should be addressed to Hugh O'Brodovich, M.D., FRCP (C), Professor of Paediatrics and Physiology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G 1X8. E-mail: hugh.obrodovich{at}sickkids.ca
We present the clinical, radiologic, and pathologic findings in lung biopsies from seven infants with atypical neonatal lung disease. All seven infants presented with tachypnea, hypoxemia, and diffuse interstitial infiltrates with overinflated lungs on chest radiographs in the first month of life. Lung biopsies from all cases showed similar pathology, with expansion of the interstitium by spindle-shaped cells containing periodic acidSchiff positive diastase labile material consistent with glycogen. Immunohistochemical staining showed these cells to be vimentin positive but negative for leucocyte common antigen, lysozyme, and other macrophage markers. Electron microscopy revealed primitive interstitial mesenchymal cells with few cytoplasmic organelles and abundant monoparticulate glycogen. Minimal or no glycogen was seen in the alveolar lining cells. Five cases were treated with pulse corticosteroids; hydroxychloroquine was added in one case. Six of seven infants have shown a favorable clinical outcome. One infant died from complications of extreme prematurity and bronchopulmonary dysplasia. Three cases that have been followed for at least 6 years have shown clinical resolution and radiographic improvement. We propose the term "pulmonary interstitial glycogenosis" of the neonate for this new entity to be differentiated from other forms of interstitial lung disease. Because abundant glycogen is not normally found in pulmonary interstitial cells, we postulate an abnormality in lung cytodifferentiation involving interstitial mesenchymal cells.
Key Words: cellular interstitial pneumonitis pulmonary interstitial glycogenosis interstitial lung disease pediatric newborn lung disease
This article has been cited by other articles:

|
 |

|
 |
 
G. H. Deutsch, L. R. Young, R. R. Deterding, L. L. Fan, S. D. Dell, J. A. Bean, A. S. Brody, L. M. Nogee, B. C. Trapnell, C. Langston, et al.
Diffuse Lung Disease in Young Children: Application of a Novel Classification Scheme
Am. J. Respir. Crit. Care Med.,
December 1, 2007;
176(11):
1120 - 1128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Deterding and L. L. Fan
Surfactant Dysfunction Mutations in Children's Interstitial Lung Disease and Beyond
Am. J. Respir. Crit. Care Med.,
October 15, 2005;
172(8):
940 - 941.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bush
Paediatric interstitial lung disease: not just kid's stuff
Eur. Respir. J.,
October 1, 2004;
24(4):
521 - 523.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Clement and committee members
Task force on chronic interstitial lung disease in immunocompetent children
Eur. Respir. J.,
October 1, 2004;
24(4):
686 - 697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
333 - 344.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Fan and C. Langston
Pediatric Interstitial Lung Disease: Children Are Not Small Adults
Am. J. Respir. Crit. Care Med.,
June 1, 2002;
165(11):
1466 - 1467.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|